Get today's news straight to your inbox

Natural Selection

Blessed be the fruit. US drugmaker Gilead Sciences pledged to invest an additional...

Bayer In The Weeds

Shares of German pharmaceuticals and life sciences giant Bayer fell 10% on Wednesday...

Innovation Pharmed Out

Swiss pharmaceutical company Roche – the world’s second-biggest – announced on Monday that...

Biotech Is The New Black

American pharmaceutical company Eli Lilly, maker of Prozac and the polio vaccine, announced...

Takeda Takes Shire

On Wednesday, Takeda Pharmaceutical’s shareholders signed off on the company’s $59 billion takeover...

A Clear Vision At Novartis

On Friday, leading Swiss drugmaker Novartis – worth over $190 billion – announced...

One Capsule To Rule Them All

News broke on Thursday that Irish biotech firm Shire had rejected a $60...

Valeant Plummets Amid Enron-Like Allegations

Valeant, a speciality drugs company, was likened to a “pharmaceutical Enron” and its stock...

Clinton Sucker Punches Drug Stocks

Hillary Clinton, possibly the next president of the US, is taking a hard...